Ticker Sage

Insider digest · BMY

Bristol Myers Squibb insider filings, Oct 2, 2026

Bristol Myers Squibb insiders filed 5 routine Form 4 reports on Oct 2, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.

What the codes mean: how to read a Form 4 · stock-based compensation.

Stock awards and grants

Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 3,125 shares or units, worth about $195,000 at the prices reported.

PersonCodeSecuritySharesPriceValueHeld after
Peter J. Arduini · directorADeferred Share Units560.897$62.40$35,00074,077
Michael R. McMullen · directorADeferred Share Units560.897$62.40$35,00017,051
Derica W. Rice · directorADeferred Share Units620.994$62.40$38,75042,085
Theodore R. Samuels, Ii. · directorADeferred Share Units821.314$62.40$51,25071,859
Phyllis R. Yale · directorADeferred Share Units560.897$62.40$35,00045,980

The filings

Bristol Myers Squibb company file → · All Bristol Myers Squibb filings notes

Disclosures

Editor holdings in BMY
The editor holds no position in Bristol Myers Squibb (BMY). As of Nov 11, 2026.
Compensation
Nobody paid for this page. No affiliate links.

A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold BMY.